Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Neutral Investing News Network
Owner: Nick Smith
Eliminating Oklahoma’s medical marijuana industry would be ‘death blow,’ costly to state

Eliminating Oklahoma’s medical marijuana industry would be ‘death blow,’ costly to state

Health Wave Partners Acquires MorningStar of Parker

Health Wave Partners Acquires MorningStar of Parker

#business: Telcos Urge Kiwis to Check Phones as 3G Shutdown Risks Loss of 111 Access

#business: Telcos Urge Kiwis to Check Phones as 3G Shutdown Risks Loss of 111 Access

Business groups appeal NJDEP PACT land use rules

Business groups appeal NJDEP PACT land use rules

Business leaders, nonprofits honored at annual EDC gala

Business leaders, nonprofits honored at annual EDC gala

New resources to support families navigating Mental Health Act

New resources to support families navigating Mental Health Act

Gov't Institution UK Research and Innovation
Owner: British Government
India and Uzbekistan Launch Landmark Pharmaceutical & Nutraceutical Trade Corridor, Unlocking Access to a USD 10 Billion Eurasian Market

India and Uzbekistan Launch Landmark Pharmaceutical & Nutraceutical Trade Corridor, Unlocking Access to a USD 10 Billion Eurasian Market

Neutral The Tribune (Chandigarh)
Owner: The Tribune Trust
ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy®  Commercialization

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® Commercialization

Neutral Investing News Network
Owner: Nick Smith
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

Neutral Investing News Network
Owner: Nick Smith
Eliminating Oklahoma’s medical marijuana industry would be ‘death blow,’ costly to state

Eliminating Oklahoma’s medical marijuana industry would be ‘death blow,’ costly to state

Health Wave Partners Acquires MorningStar of Parker

Health Wave Partners Acquires MorningStar of Parker

#business: Telcos Urge Kiwis to Check Phones as 3G Shutdown Risks Loss of 111 Access

#business: Telcos Urge Kiwis to Check Phones as 3G Shutdown Risks Loss of 111 Access

Business groups appeal NJDEP PACT land use rules

Business groups appeal NJDEP PACT land use rules

Business leaders, nonprofits honored at annual EDC gala

Business leaders, nonprofits honored at annual EDC gala

New resources to support families navigating Mental Health Act

New resources to support families navigating Mental Health Act

India and Uzbekistan Launch Landmark Pharmaceutical & Nutraceutical Trade Corridor, Unlocking Access to a USD 10 Billion Eurasian Market

India and Uzbekistan Launch Landmark Pharmaceutical & Nutraceutical Trade Corridor, Unlocking Access to a USD 10 Billion Eurasian Market

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy®  Commercialization

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® Commercialization

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

First Subjects Dosed in Cocrystal Pharma's Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Show More

Video Stories

YouTube video thumbnail: What Is Biocomputing?
Play
What Is Biocomputing?
YouTube video thumbnail: How Does Touch Affect Our Mental and Physical Health?
Play
How Does Touch Affect Our Mental and Physical Health?
YouTube video thumbnail: Mindfulness Meditation: How It Works and Why It’s So Popular
Play
Mindfulness Meditation: How It Works and Why It’s So Popular
YouTube video thumbnail: Was I Wrong About Alternative Therapies? A Sceptic’s Guide to Wellness
Play
Was I Wrong About Alternative Therapies? A Sceptic’s Guide to Wellness

Video Title

Press Releases

Attorney General Jackley Announces State Reaches Mayday Health Settlement and Removal of Unlawful Abortion Pill Ads

Attorney General Jackley Announces State Reaches Mayday Health Settlement and Removal of Unlawful Abortion Pill Ads

Attorney General Jackley Announces State Reaches Mayday Health Settlement and Removal of Unlawful Abortion Pill Ads

Attorney General Jackley Announces State Reaches Mayday Health Settlement and Removal of Unlawful Abortion Pill Ads

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions